Brief: ViroGates Announces Delay In Development And Launch Of suPARnostic POC+ Product
08/01/2021 06:19
Jan 8 (Reuters) - ViroGates A/S VIROG.CO :
* SAID ON THURSDAY DEVELOPMENT OF CO’S NEW POINT-OF-CARE
PRODUCT,
SUPARNOSTIC® POC+, WILL BE DELAYED TO H2 2021
* REASON FOR THE DELAY IS RELATED TO QC/QA SPECIFICATION
DEVELOPMENT THAT HAS BEEN DELAYED AS RESULT OF COVID-19 PANDEMIC
IN AUSTRIA DURING H2 2020
Source text for Eikon: urn:newsml:reuters.com:*:nRBB3TvVlv
Further company coverage: VIROG.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))